1. Home
  2. ICLK vs ENLV Comparison

ICLK vs ENLV Comparison

Compare ICLK & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICLK
  • ENLV
  • Stock Information
  • Founded
  • ICLK 2009
  • ENLV 2005
  • Country
  • ICLK Hong Kong
  • ENLV Israel
  • Employees
  • ICLK N/A
  • ENLV N/A
  • Industry
  • ICLK Computer Software: Prepackaged Software
  • ENLV Biotechnology: Pharmaceutical Preparations
  • Sector
  • ICLK Technology
  • ENLV Health Care
  • Exchange
  • ICLK Nasdaq
  • ENLV Nasdaq
  • Market Cap
  • ICLK 29.1M
  • ENLV 25.9M
  • IPO Year
  • ICLK 2017
  • ENLV 1995
  • Fundamental
  • Price
  • ICLK $8.58
  • ENLV $1.20
  • Analyst Decision
  • ICLK
  • ENLV Strong Buy
  • Analyst Count
  • ICLK 0
  • ENLV 2
  • Target Price
  • ICLK N/A
  • ENLV $9.50
  • AVG Volume (30 Days)
  • ICLK 110.3K
  • ENLV 462.9K
  • Earning Date
  • ICLK 11-27-2024
  • ENLV 11-29-2024
  • Dividend Yield
  • ICLK N/A
  • ENLV N/A
  • EPS Growth
  • ICLK N/A
  • ENLV N/A
  • EPS
  • ICLK N/A
  • ENLV N/A
  • Revenue
  • ICLK $130,443,999.00
  • ENLV N/A
  • Revenue This Year
  • ICLK $26.49
  • ENLV N/A
  • Revenue Next Year
  • ICLK $12.11
  • ENLV N/A
  • P/E Ratio
  • ICLK N/A
  • ENLV N/A
  • Revenue Growth
  • ICLK N/A
  • ENLV N/A
  • 52 Week Low
  • ICLK $1.03
  • ENLV $0.81
  • 52 Week High
  • ICLK $8.76
  • ENLV $4.59
  • Technical
  • Relative Strength Index (RSI)
  • ICLK 71.58
  • ENLV 50.34
  • Support Level
  • ICLK $6.97
  • ENLV $1.13
  • Resistance Level
  • ICLK $8.14
  • ENLV $1.24
  • Average True Range (ATR)
  • ICLK 0.93
  • ENLV 0.10
  • MACD
  • ICLK 0.13
  • ENLV 0.01
  • Stochastic Oscillator
  • ICLK 96.22
  • ENLV 58.10

About ICLK iClick Interactive Asia Group Limited

iClick Interactive Asia Group Ltd is an enterprise and marketing cloud Platform in China. It offers a consumer full lifecycle solution that addresses client's needs from traffic acquisition, customer relations management, and business decision optimization driven by data analytics in the retail era. It has two operating segments: Marketing Solutions, and Enterprise Solutions. Geographically, it derives the majority revenue from Mainland China and also has a presence in Hong Kong and other countries.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Share on Social Networks: